Why is Medicamen Biotec falling/rising?

As of 06-Nov, Medicamen Biotech Ltd's stock price is rising, currently at 396.05, reflecting an increase of 11.45 or 2.98%. The stock has shown strong performance recently, gaining 12.51% over the last five days and outperforming its sector by 3.75% today. It reached an intraday high of Rs 403.5, indicating positive momentum. Additionally, the stock has experienced a significant return of 31.21% over the past month, contrasting with the Sensex's modest gain of 1.86%. The rising investor participation, with an increase in delivery volume, suggests growing interest in the stock, although no specific positive or negative factors were provided to further explain its recent movement.
Broader Market Context: In the short term, Medicamen Biotech's stock has outperformed the Sensex, which has declined by 1.30% over the past week while the stock itself has risen by 9.71%. This divergence highlights the stock's relative strength compared to the broader market. However, it is important to note that the stock has underperformed over longer periods, with a year-to-date decline of 22.23% compared to the Sensex's gain of 6.62%. This contrast indicates that while the stock is currently experiencing a positive trend, it has faced significant challenges in the longer term.